U.S. Stoma/Ostomy Care Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

U.S. Stoma/Ostomy Care Market Overview

The U.S. stoma/ostomy care market was valued at USD 2.13 billion in 2025 and is projected to reach USD 3.24 billion by 2033, growing at a CAGR of 5.4% from 2026 to 2033. The market is witnessing steady growth driven by the rising prevalence of colorectal cancer, inflammatory bowel disease, and bladder cancer, which are increasing the number of ostomy procedures across the country.

The growing aging population in the U.S., along with higher surgical intervention rates for chronic gastrointestinal and urological conditions, is significantly contributing to demand for ostomy care products such as pouches, skin barriers, and accessories. In addition, continuous advancements in skin-friendly adhesive technologies, odor-control systems, and discreet wearable designs are improving patient comfort and quality of life. Expanding home healthcare adoption and strong reimbursement support are further encouraging long-term product usage and driving sustained market expansion.

Key Market Trends & Insights

• The Ostomy Bags segment led the market by product type with a 44.2% share in 2025, driven by strong demand for leak-proof, odor-control, and skin-friendly pouching systems used in long-term patient care.
• The Skin Barriers segment is the fastest-growing product type, projected to expand at a CAGR of 6.9% from 2026 to 2033, supported by rising focus on peristomal skin protection and complication prevention.
• The Ileostomy segment is the fastest-growing application type, projected to register a CAGR of 6.7% from 2026 to 2033, driven by increasing prevalence of inflammatory bowel disease and Crohn’s disease.
• The Pharmacies segment dominates the point of sale category with a 38.9% revenue share in 2025, driven by strong accessibility and regular prescription fulfillment for ostomy supplies. Patients prefer pharmacies due to immediate availability and pharmacist assistance in product selection.
• Colostomy segment accounts for 47.5% of the market in 2025, preferred by the high number of colorectal cancer-related surgeries in the U.S. This procedure is more commonly performed compared to other ostomy types, leading to sustained demand for related care products
• E-Pharmacy segment is the fastest-growing point of sale category, with a CAGR of 7.3% from 2026 to 2033, driven by rising demand for discreet purchasing and doorstep delivery of medical supplies. Patients increasingly prefer online platforms for privacy and convenience in managing chronic conditions.

Market Size & Forecast

• Global Market Value (2025): USD 2.13 Billion
• Expected Market Value (2033): USD 3.24 Billion
• Forecast CAGR (2026–2033): 5.4%

Report Scope and U.S. Stoma/Ostomy Care Market Segmentation

U.S. Stoma/Ostomy Care Market Trends

Trend: Rising Shift Toward Advanced Skin Protection Technologies

Healthcare providers and manufacturers are increasingly focusing on next-generation skin barrier systems designed to reduce peristomal skin complications, improve adhesion durability, and enhance patient comfort. Innovations such as hydrocolloid-based barriers, silicone adhesives, and extended-wear pouching systems are gaining strong adoption in the U.S. market. These advancements are improving long-term patient outcomes, particularly among elderly and post-surgical colorectal cancer patients, while supporting better quality of life through reduced leakage and skin irritation risks.

U.S. Stoma/Ostomy Care Market Dynamics

Key Market Driver: Increasing Prevalence of Colorectal Cancer and IBD-Related Surgeries

The rising incidence of colorectal cancer, Crohn’s disease, and ulcerative colitis in the U.S. is significantly driving demand for ostomy procedures and long-term care products. A growing number of patients require colostomy, ileostomy, and urostomy surgeries, creating sustained demand for ostomy bags, skin barriers, and accessories. Strong reimbursement coverage and advanced hospital infrastructure further support product adoption across both inpatient and home-care settings, ensuring continuous market expansion.

Key Restraint/Challenge: Skin Complications and Product-Related Discomfort Issues

A key challenge in the U.S. stoma/ostomy care market is the prevalence of peristomal skin complications, including irritation, leakage, and allergic reactions to adhesives. Despite product advancements, many patients experience discomfort and difficulty achieving a secure fit, leading to frequent product changes and reduced quality of life. This creates barriers to long-term compliance and increases overall healthcare costs, particularly among elderly and sensitive-skin patient populations.

For instance, patients undergoing ileostomy surgery often report frequent leakage episodes within the first months post-operation due to high-output stoma output and difficulty maintaining a stable seal, increasing reliance on repeated appliance changes and clinical support. This creates barriers to long-term compliance and increases overall healthcare costs, particularly among elderly and sensitive-skin patient populations.

Key Market Opportunity: Expansion of E-Commerce and Home-Based Ostomy Care Services

The rapid growth of e-commerce and e-pharmacy platforms presents a major opportunity for market expansion in the U.S. ostomy care sector. Patients increasingly prefer discreet home delivery of ostomy supplies, supported by subscription-based models and telehealth-assisted care guidance. This shift is enabling better product accessibility, improved patient adherence, and continuous demand generation outside traditional hospital and pharmacy channels.

U.S. Stoma/Ostomy Care Market Scope

The U.S. Stoma/Ostomy Care market is segmented on the basis of product type, application, point of sale, and end user setting.

• By Product Type

On the basis of product type, the U.S. stoma/ostomy care market is segmented into ostomy bags, skin barriers, pastes and powders, and other accessories. The Ostomy Bags segment dominated the market with a 44.2% share in 2025, owing to its essential role in waste management after stoma surgery and its continuous replacement requirement. These products are widely used across colostomy, ileostomy, and urostomy patients, making them the most critical and frequently purchased item in ostomy care. Strong demand for leak-proof designs, odor control features, and improved comfort solutions is further supporting segment dominance. Hospitals and home-care patients consistently rely on ostomy bags for daily life management. Established reimbursement coverage and wide availability through pharmacies also reinforce its leading position in the market.

The Skin Barriers segment is projected to be the fastest growing from 2026 to 2033, expanding at a CAGR of 6.9%, driven by increasing clinical focus on preventing peristomal skin complications. These products help reduce irritation, leakage, and infection risks, which are common challenges faced by ostomy patients. Rising awareness among healthcare professionals and patients regarding skin protection is boosting adoption rates. Continuous innovation in hydrocolloid-based and silicone-based formulations is improving wear time and adhesion quality. Increasing preference for long-term comfort and reduced product change frequency is further accelerating growth in this segment.

• By Application

On the basis of application, the market is segmented into colostomy, ileostomy, and urostomy. The Colostomy segment dominated the market with a 47.5% share in 2025, primarily due to the high number of colorectal cancer-related surgeries in the U.S. This procedure is more commonly performed compared to other ostomy types, leading to sustained demand for related care products. Colostomy patients often require long-term use of ostomy bags and accessories, ensuring continuous product consumption. The segment benefits from strong hospital-based surgical volumes and well-established post-operative care pathways. Increasing elderly population and rising colorectal disease burden further support its dominance.

The Ileostomy segment is expected to be the fastest growing from 2026 to 2033, expanding at a CAGR of 6.7%, driven by rising incidence of inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis. Patients undergoing ileostomy often require advanced pouching systems due to higher output and management complexity. Growing surgical intervention rates among younger and middle-aged populations are expanding the patient base. Increasing need for improved skin protection and leakage prevention is also boosting demand. Continuous product innovation tailored to high-output stoma care is further supporting segment growth.

• By Point of Sale

On the basis of point of sale, the market is segmented into pharmacies, mail order companies, medical surgical supply houses, and e-pharmacy. The Pharmacies segment dominated the market with a 38.9% share in 2025, driven by strong accessibility and regular prescription fulfillment for ostomy supplies. Patients prefer pharmacies due to immediate availability and pharmacist assistance in product selection. Established retail networks ensure consistent supply for long-term ostomy users. Pharmacies also play a key role in supporting post-discharge patients from hospitals. Strong reimbursement frameworks further support high usage through this channel.

The E-Pharmacy segment is projected to be the fastest growing from 2026 to 2033, expanding at a CAGR of 7.3%, driven by rising demand for discreet purchasing and doorstep delivery of medical supplies. Patients increasingly prefer online platforms for privacy and convenience in managing chronic conditions. Subscription-based models are improving adherence and reducing supply interruptions. Expansion of digital healthcare infrastructure and telehealth integration is supporting market penetration. Growing internet usage among elderly caregivers and patients is further accelerating adoption.

• By End User Setting

On the basis of end user setting, the market is segmented into at home care, hospitals, nursing homes, and old age care settings. The At Home Care segment dominated the market with a 49.6% share in 2025, as most ostomy patients transition to home-based long-term care after surgery. Patients rely heavily on self-management routines and regular supply of ostomy products in home settings. Increasing preference for outpatient recovery and reduced hospital stay duration is supporting this dominance. Home care offers cost efficiency and improved patient comfort, making it the preferred care environment. Availability of e-commerce and pharmacy delivery further strengthens this segment.

The Nursing Homes segment is projected to be the fastest growing from 2026 to 2033, expanding at a CAGR of 7.1%, driven by rising elderly population requiring continuous assisted care. Older patients are more likely to undergo colorectal and urological procedures leading to ostomy creation. Nursing homes provide structured monitoring and regular product replacement support. Increasing prevalence of chronic diseases among aging populations is further boosting demand. Expansion of long-term care facilities in the U.S. is also contributing to segment growth.

U.S. Stoma/Ostomy Care Market Share

The U.S. Stoma/Ostomy Care industry is primarily led by well-established companies, including:

• Coloplast A/S (Denmark)
• Convatec Group plc (U.K.)
• Hollister Incorporated (U.S.)
• Nu-Hope Laboratories, Inc. (U.S.)
• Marlen Manufacturing & Development Co. (U.S.)
• Cymed Ostomy Co. (U.S.)
• Nu-Hope Laboratories (U.S.)
• Flexicare (Group) Limited (U.K.)
• B. Braun SE (Germany)
• 3M U.S.)
• Alcare Co., Ltd. (Japan)
• Torbot Group Inc. (U.S.)
• Welland Medical Limited (U.K.)
• Salts Healthcare Ltd (U.K.)
• Oakmed Healthcare (U.K.)
• Pelican Healthcare Ltd (U.K.)
• Genairex Inc. (U.S.)
• Clinimed (U.S.)
• Eakin Healthcare Group (U.K.)

Latest Developments in U.S. Stoma/Ostomy Care Market

• In January 2025, Coloplast announced the expansion of its next-generation SenSura Mio ostomy care portfolio in the U.S., featuring improved elastic adhesive technology designed to adapt to body movement and reduce leakage risk. The expansion focuses on enhancing comfort, wear time, and skin protection for colostomy and ileostomy patients. It reflects increasing demand for advanced, patient-centric ostomy solutions in home-care settings. The innovation strengthens Coloplast’s footprint in the U.S. ostomy care segment
• In June 2024, Hollister Incorporated introduced upgrades to its CeraPlus ostomy skin barrier line in the U.S. market, incorporating Remois technology to help maintain skin moisture and reduce irritation. The product enhancement is designed to improve peristomal skin health and reduce complications from prolonged wear. It addresses a key clinical challenge faced by long-term ostomy patients. The update supports improved patient comfort and reduced leakage risk
• In March 2023, ConvaTec launched its Esteem Body convex ostomy system in the U.S., designed to provide improved security and flexibility for active ostomy patients. The system aims to reduce leakage and improve adhesion performance during daily movement. It is targeted toward patients requiring convex pouching solutions for challenging stoma conditions. The launch strengthens ConvaTec’s product portfolio in advanced ostomy care
• In October 2022, Hollister Incorporated expanded its U.S. distribution network for ostomy care products through enhanced partnerships with major medical supply distributors and e-commerce channels. The expansion improved accessibility of ostomy supplies across home-care and hospital discharge patients. It supports growing demand for convenient delivery and recurring supply models. The strategy strengthens Hollister’s presence in both retail and institutional channels
• In May 2021, Coloplast launched enhanced digital support services in the U.S., including expanded ostomy care education platforms and virtual patient assistance programs. The initiative focuses on improving post-surgical recovery and self-care education for ostomy patients. It supports better long-term adherence to ostomy management routines. The program helps patients transition from hospital to home care more effectively

SKU-66971